Lysosomal Storage Disorders in the Newborn

Lysosomal storage disorders are rare inborn errors of metabolism, with a combined incidence of 1 in 1500 to 7000 live births. These relatively rare disorders are seldom considered when evaluating a sick newborn. A significant number of the >50 different lysosomal storage disorders, however, do manifest in the neonatal period and should be part of the differential diagnosis of several perinatal phenotypes. We review the earliest clinical features, diagnostic tests, and treatment options for lysosomal storage disorders that can present in the newborn. Although many of the lysosomal storage disorders are characterized by a range in phenotypes, the focus of this review is on the specific symptoms and clinical findings that present in the perinatal period, including neurologic, respiratory, endocrine, and cardiovascular manifestations, dysmorphic features, hepatosplenomegaly, skin or ocular involvement, and hydrops fetalis/congenital ascites. A greater awareness of these features may help to reduce misdiagnosis and promote the early detection of lysosomal storage disorders. Implementing therapy at the earliest stage possible is crucial for several of the lysosomal storage disorders; hence, an early appreciation of these disorders by physicians who treat newborns is essential.

[1]  M. Hod,et al.  Isolated fetal ascites caused by Wolman disease , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  H. Enders,et al.  Restrictive dermopathy: report and review. , 1997, American journal of medical genetics.

[3]  N. Ozbek,et al.  A Very Unusual Presentation of Niemann-Pick Disease Type B in an Infant: Similar Findings to Congenital Lobar Emphysema , 2005, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[4]  M. Verity,et al.  Infantile Pompe's disease, lipid storage, and partial carnitine deficiency , 1991, Muscle & nerve.

[5]  David J. Loren,et al.  Sialidosis Presenting as Severe Nonimmune Fetal Hydrops is Associated with Two Novel Mutations in Lysosomal α-Neuraminidase , 2005, Journal of Perinatology.

[6]  H. Sudhof,et al.  [Congenital Gaucher's disease in erythroblastosis and vascular sclerosis]. , 1954, Klinische Wochenschrift.

[7]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[8]  A. Tylki-Szymańska,et al.  Neuraminidase deficiency presenting as a nephrosialidosis: The first case detected in Poland , 1996, Acta paediatrica Japonica : Overseas edition.

[9]  T. Daly,et al.  Gene therapy for lysosomal storage diseases. , 1998, Expert opinion on investigational drugs.

[10]  C. Hollak,et al.  Novel therapeutic targets for the treatment of Fabry disease , 2007, Expert opinion on therapeutic targets.

[11]  M. Elleder,et al.  A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. , 2001, Human molecular genetics.

[12]  M. Rybojad,et al.  [Extensive Mongolian spot related to Hurler disease]. , 1999, Annales de dermatologie et de venereologie.

[13]  M. Elleder,et al.  Prosaposin deficiency -- a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient. , 2005, Neuropediatrics.

[14]  H. Moser,et al.  Early manifestations of multiple sulfatase deficiency. , 1984, The Journal of pediatrics.

[15]  M. Senat,et al.  Second‐trimester diagnosis of mucopolysaccharidosis type IV a presenting as hydrops fetalis , 2006, Prenatal diagnosis.

[16]  E. Blair,et al.  Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications. , 1997, Journal of clinical pathology.

[17]  M. Nakayama,et al.  A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules. , 2001, The Journal of pediatrics.

[18]  A. Smits,et al.  Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[19]  J. Clarke,et al.  Early infantile variant of Krabbe globoid cell leucodystrophy with lung involvement. , 1981, Archives of disease in childhood.

[20]  R. Schiffmann,et al.  Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. , 1998, Human gene therapy.

[21]  E. Sidransky,et al.  PERINATAL LETHAL GAUCHER DISEASE: A DISTINCT PHENOTYPE ALONG THE NEURONOPATHIC CONTINUUM , 2005, Fetal and pediatric pathology.

[22]  F. Van hoof,et al.  Ocular findings in I-cell disease (mucolipidosis type II). , 1977, American journal of ophthalmology.

[23]  K. Zerres,et al.  Nonimmune hydrops fetalis with galactosialidosis: consequences for family planning. , 1996, Fetal diagnosis and therapy.

[24]  T. Butters Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders , 2007, Expert opinion on pharmacotherapy.

[25]  E. M. Schoonderwaldt,et al.  In‐utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[26]  W. Mcalister,et al.  Neonatal mucolipidosis II (I-cell disease) with dysharmonic epiphyseal ossification and butterfly vertebral body. , 1996, Journal of perinatology : official journal of the California Perinatal Association.

[27]  C. Noehammer,et al.  Metabolic cardiomyopathies , 2000, International journal of experimental pathology.

[28]  D. Roberts,et al.  Diagnosis of unsuspected fetal metabolic storage disease by routine placental examination. , 1991, Pediatric pathology.

[29]  E. Sidransky,et al.  Hydrops fetalis: lysosomal storage disorders in extremis. , 1999, Advances in pediatrics.

[30]  A. Reuser,et al.  Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II. , 2007, Molecular genetics and metabolism.

[31]  N. Conradi,et al.  Early-infantile galactosialidosis with multiple brain infarctions: morphological, neuropathological and neurochemical findings , 1996, Acta Neuropathologica.

[32]  W. Sly,et al.  PCR-based restriction fragment length polymorphism and haplotype of the most common mutation L176F in the beta-glucuronidase gene. , 2007, Genetic testing.

[33]  J. Fletcher Screening for lysosomal storage disorders—A clinical perspective , 2006, Journal of Inherited Metabolic Disease.

[34]  N. S. Warren,et al.  Fetal mucolipidosis II (I-cell disease): radiologic and pathologic correlation , 2006, Pediatric Radiology.

[35]  J. Kelly,et al.  Pharmacologic chaperoning as a strategy to treat Gaucher disease , 2007, The FEBS journal.

[36]  R. Barone,et al.  Inter‐ and intrafamilial variability in mucolipidosis II (I‐cell disease) , 1995, Clinical genetics.

[37]  R. Carmi,et al.  Niemann-Pick disease associated with nonimmune hydrops fetalis. , 1990, American journal of obstetrics and gynecology.

[38]  M. Sanseverino,et al.  Investigation of lysosomal storage diseases in nonimmune hydrops fetalis , 2004, Prenatal diagnosis.

[39]  O. Linderkamp,et al.  Refractory congenital ascites as a manifestation of neonatal sialidosis: clinical, biochemical and morphological studies in a newborn Syrian male infant. , 1999, American journal of perinatology.

[40]  E. Çakir,et al.  A case of I-cell disease (mucolipidosis II) presenting with craniosynostosis , 2002, Child's Nervous System.

[41]  M. Akçam Infantile Pompe's disease presenting with pulmonary infections during the newborn period. , 2004, Saudi Medical Journal.

[42]  H. Patriquin,et al.  Neonatal mucolipidosis II (I-cell disease): clinical and radiologic features in three cases. , 1977, AJR. American journal of roentgenology.

[43]  A. Kher,et al.  Mucolipidoses—II: a report of three cases , 1995, Indian journal of pediatrics.

[44]  B. Siassi,et al.  A rare presentation of Pompe disease with massive hypertrophic cardiomyopathy at birth , 2002, Journal of perinatal medicine.

[45]  Wuh-Liang Hwu,et al.  A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. , 2006, The Journal of pediatrics.

[46]  R. D. Wilson,et al.  Morquio disease presenting as hydrops fetalis and enzyme analysis of chorionic villus tissue in a subsequent pregnancy. , 1987, Pediatric pathology.

[47]  A. Beaudet,et al.  Variation in the phenotypic expression of β-glucuronidase deficiency , 1975 .

[48]  E. Cutz,et al.  Congenital ascites as a presenting sign of lysosomal storage disease. , 1984, The Journal of pediatrics.

[49]  C. Vaillant,et al.  Forme respiratoire néonatale létale de la maladie de Niemann-Pick C2 et diagnostic anténatal par l'étude des mutations du gène HE1/NPC2 , 2005 .

[50]  D. Landau,et al.  A novel mutation in the SLC17A5 gene causing both severe and mild phenotypes of free sialic acid storage disease in one inbred Bedouin kindred. , 2004, Molecular genetics and metabolism.

[51]  E. Zammarchi,et al.  β‐galactosidase gene mutations affecting the lysosomal enzyme and the elastin‐binding protein in GM1‐gangliosidosis patients with cardiac involvement , 2000, Human mutation.

[52]  M. Verity,et al.  Infantile Pompe's disease, lipid storage, and partial carnitine deficiency , 1991, Muscle & nerve.

[53]  D. Sherer,et al.  Congenital ichthyosis with restrictive dermopathy and gaucher disease: A new syndrome with associated prenatal diagnostic and pathology findings , 1993, Obstetrics and gynecology.

[54]  W. Krivit Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases , 2004, Springer Seminars in Immunopathology.

[55]  S. Ishii,et al.  Active‐site‐specific chaperone therapy for Fabry disease , 2007, The FEBS journal.

[56]  Christopher P Austin,et al.  Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease , 2007, Proceedings of the National Academy of Sciences.

[57]  S. Withers,et al.  Pharmacological Enhancement of β-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff Patients* , 2004, Journal of Biological Chemistry.

[58]  E. Lemyre,et al.  Clinical spectrum of infantile free sialic acid storage disease. , 1999, American journal of medical genetics.

[59]  J. Callahan,et al.  Infantile sialidosis: a phenocopy of type 1 GM1 gangliosidosis distinguished by genetic complementation and urinary oligosaccharides. , 1979, American journal of human genetics.

[60]  E. Sidransky,et al.  Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene. , 1997, American journal of medical genetics.

[61]  S. Panny,et al.  Hydrops fetalis associated with Gaucher disease. , 1984, Pathology, research and practice.

[62]  Yutaka Uno,et al.  HISTOCHEMICAL STUDIES IN WOLMAN'S DISEASE – REPORT OF AN AUTOPSY CASE ACCOMPANIED WITH A LARGE AMOUNT OF MILKY ASCITES – , 1973, Acta pathologica japonica.

[63]  Peter Congdon,et al.  Multiple sulphatase deficiency presenting at birth , 1986, Clinical genetics.

[64]  N. Amano,et al.  β‐Galactosidase–neuraminidase deficiency (galactosialidosis): Clinical, pathological, and enzymatic studies in a postmortem case , 1983, Annals of neurology.

[65]  F. Gottrand,et al.  [Fatal neonatal respiratory distress in Niemann-Pick C2 and prenatal diagnosis with mutations in gene HE1/NPC2]. , 2005, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[66]  G. Hutchins,et al.  Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome. , 1978, American heart journal.

[67]  H. Kayserili,et al.  Short Femurs Detected at 25 and 31 Weeks of Gestation Diagnosed as Leroy I-Cell Disease in the Postnatal Period: A Report of Two Cases , 2007, Fetal Diagnosis and Therapy.

[68]  H. Osawa,et al.  Identification of Gaucher cells in the chorionic villi associated with recurrent hydrops fetalis. , 1998, Placenta.

[69]  W. Sly,et al.  Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. , 1996, American Journal of Human Genetics.

[70]  M. Tasso,et al.  GM1-Gangliosidosis presenting as nonimmune hydrops fetalis: a case report , 1996, Journal of perinatal medicine.

[71]  I. Krägeloh-Mann,et al.  In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients. , 2006, Experimental hematology.

[72]  F. Gottrand,et al.  Neonatal cholestasis and infantile Gaucher disease: a case report , 2002, Acta paediatrica.

[73]  J. Groener,et al.  New mutations in two Dutch patients with early infantile galactosialidosis. , 2003, Molecular genetics and metabolism.

[74]  V. Wiley,et al.  Application of tandem mass spectrometry to biochemical genetics and newborn screening. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[75]  D. Bonneau,et al.  Prenatal diagnosis of Gaucher's disease type 2. Ultrasonographic, biochemical and histological aspects , 2000, Prenatal diagnosis.

[76]  R. Choong,et al.  Collodion babies with Gaucher's disease. , 1988, Archives of disease in childhood.

[77]  G. Donnell,et al.  Beta-glucuronidase deficiency. A heterogeneous mucopolysaccharidosis. , 1985, American journal of diseases of children.

[78]  W. Bradford,et al.  Infantile sialic acid storage disease: a rare cause of cytoplasmic vacuolation in pediatric patients. , 1995, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

[79]  S. Gerson,et al.  Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) , 2002, Bone Marrow Transplantation.

[80]  Y. Nevo,et al.  Early peripheral nervous system manifestations of infantile Krabbe disease. , 2003, Pediatric neurology.

[81]  M. Poe,et al.  Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. , 2005, The New England journal of medicine.

[82]  P. Morel,et al.  Tache mongolique étendue révélant une maladie de Hurler. , 1999 .

[83]  P. Meikle,et al.  Diagnosis of lysosomal storage disorders: current techniques and future directions , 2004, Expert review of molecular diagnostics.

[84]  D. Cole,et al.  Mucolipidosis II presenting as severe neonatal hyperparathyroidism , 2005, European Journal of Pediatrics.

[85]  K. Lukong,et al.  Clinical presentation of congenital sialidosis in a patient with a neuraminidase gene frameshift mutation , 2001, European Journal of Pediatrics.

[86]  L. Becker,et al.  Vascular pathology in galactosialidosis. , 1999, Ultrastructural pathology.

[87]  P. McCourt,et al.  Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. , 1991, American journal of human genetics.

[88]  M. Bashyam,et al.  Farber lipogranulomatosis: clinical and molecular genetic analysis reveals a novel mutation in an Indian family , 2006, Journal of Human Genetics.

[89]  A. Poulos,et al.  Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidoses , 1989, European Journal of Pediatrics.

[90]  P. Josset,et al.  Perinatal‐lethal Gaucher disease , 2003, American journal of medical genetics. Part A.

[91]  M. Owada,et al.  [Lysosomal disorders]. , 2002, Ryoikibetsu shokogun shirizu.

[92]  D. Chitayat,et al.  Early-infantile galactosialidosis: prenatal presentation and postnatal follow-up. , 1999, American journal of medical genetics.

[93]  A. Redington,et al.  Fragile X mental retardation. , 1990, Archives of disease in childhood.

[94]  C. Peters,et al.  Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines , 2003, Bone Marrow Transplantation.

[95]  W. Schlote,et al.  Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria , 1986, Human Genetics.

[96]  S. Sherlock,et al.  Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. , 1993, The Journal of pediatrics.

[97]  R. Dwek,et al.  Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase , 2004, Nature Genetics.

[98]  J. Nelson,et al.  Foamy changes of placental cells in probable beta glucuronidase deficiency associated with hydrops fetalis. , 1993, Journal of clinical pathology.

[99]  D. Chace,et al.  The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. , 2002, Annual review of genomics and human genetics.

[100]  V. Yu,et al.  Nonimmunologic Hydrops Fetalis: A Review of 61 Cases , 1982, Obstetrics and gynecology.

[101]  J. Hoo,et al.  Difficulty in Recognizing Multiple Sulfatase Deficiency in an Infant , 2006, Pediatrics.

[102]  M. Groll,et al.  Hydrops fetalis due to infantile Gaucher's disease. , 1973, The Journal of pediatrics.

[103]  R. Schreiber,et al.  Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly. , 2001, Journal of pediatric gastroenterology and nutrition.

[104]  I. Akaboshi,et al.  The infantile form of sialidosis type II associated with congenital adrenal hyperplasia: Possible linkage between HLA and the neuraminidase deficiency gene , 1985, Human Genetics.

[105]  L. Gort,et al.  A new infantile case of α-N-acetylgalactosaminidase deficiency. Cardiomyopathy as a presenting symptom , 2007, Journal of Inherited Metabolic Disease.

[106]  M. Beck,et al.  Neuraminidase deficiency presenting as non-immune hydrops fetalis , 1984, European Journal of Pediatrics.

[107]  Atul Mehta,et al.  Lysosomal Storage Disorders , 2005 .

[108]  R. Wevers,et al.  HPLC analysis of oligosaccharides in urine from oligosaccharidosis patients. , 1994, Clinical chemistry.

[109]  H. Tamary,et al.  GM1 gangliosidosis presenting as neonatal ascites. , 1982, The Journal of pediatrics.

[110]  R. Froissart,et al.  Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis). , 1996, Clinica chimica acta; international journal of clinical chemistry.

[111]  A. Sewell,et al.  Fetal presentation of morquio disease type A , 1992, Prenatal diagnosis.

[112]  E. Kattner,et al.  Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease , 1997, European Journal of Pediatrics.

[113]  R. Saul,et al.  Prenatal mucolipidosis type II (I‐cell disease) can present as Pacman dysplasia , 2005, American journal of medical genetics. Part A.

[114]  R. Bouvier,et al.  Clinical, morphological, and molecular aspects of sialic acid storage disease manifesting in utero , 2005, Journal of Medical Genetics.

[115]  K. Murphy,et al.  Recurrent Fetal Hydrops due to Mucopolysaccharidoses Type VII , 2006, Fetal Diagnosis and Therapy.

[116]  P. Meikle,et al.  Lysosomal storage disorders: emerging therapeutic options require early diagnosis , 2003, European Journal of Pediatrics.

[117]  Barry Byrne,et al.  Diagnostic challenges for Pompe disease: An under-recognized cause of floppy baby syndrome , 2006, Genetics in Medicine.

[118]  W. Sly,et al.  Mucopolysaccharidosis VII (beta-glucuronidase deficiency) presenting as nonimmune hydrops fetalis. , 1982, The Journal of pediatrics.

[119]  Anthony H. Futerman,et al.  The cell biology of lysosomal storage disorders , 2004, Nature Reviews Molecular Cell Biology.

[120]  G. Coppa,et al.  Neonatal mucolipidosis II (I-cell disease): clinical, radiological and biochemical studies in a case. , 1980, Helvetica paediatrica acta.

[121]  E. Sidransky,et al.  Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease. , 1995, American journal of medical genetics.

[122]  R. Van Tiggelen,et al.  Gaucher disease , 2019, Haematology.

[123]  Yoshiyuki Suzuki,et al.  Fibroblast screening for chaperone therapy in beta-galactosidosis. , 2006, Brain & development.

[124]  I. Liebaers,et al.  Unusual early manifestation of multiple sulfatase deficiency. , 1981, Annales de radiologie.

[125]  J. Metzl,et al.  An Interesting Case of Infant Sudden Death: Severe Hypertrophic Cardiomyopathy in Pompe's Disease , 1999, Pacing and clinical electrophysiology : PACE.

[126]  J. Hoeg,et al.  Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. , 1984, American journal of human genetics.

[127]  Seng H. Cheng,et al.  Cell and gene-based therapies for the lysosomal storage diseases. , 2006, Current gene therapy.

[128]  J. Ibrahim,et al.  Transient Neonatal Hyperparathyroidism: A Presenting Feature of Mucolipidosis Type II , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[129]  F. Ovali,et al.  Congenital sialidosis. , 1998, The Turkish journal of pediatrics.

[130]  P. Meikle,et al.  Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. , 2001, Clinical chemistry.

[131]  E. Bayever,et al.  The status of hematopoietic stem cell transplantation in lysosomal storage disease. , 2003, Pediatric neurology.

[132]  J. Roth,et al.  Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants. , 2006, American journal of physiology. Cell physiology.

[133]  A. Ballabio,et al.  Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[134]  S. Brooks,et al.  Neonatal Gaucher Disease Presenting as Persistent Thrombocytopenia , 2005, Journal of Perinatology.

[135]  S. Withers,et al.  High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones. , 2007, Chemistry & biology.

[136]  Yoshiyuki Suzuki,et al.  Fibroblast screening for chaperone therapy in β-galactosidosis , 2006, Brain and Development.

[137]  J. Callahan,et al.  Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model? , 1994, Biochemical medicine and metabolic biology.

[138]  Y. Eto,et al.  Pathological and biochemical studies of fetal Krabbe disease , 1994, Brain and Development.

[139]  G. Mieli-Vergani,et al.  Fetal ascites: an unusual presentation of Niemann-Pick disease type C. , 1989, Archives of disease in childhood.

[140]  A. Beaudet,et al.  Genetics and biochemistry of variant human phenotypes , 1989 .

[141]  A. Ballabio,et al.  Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[142]  J. Boelens Trends in haematopoietic cell transplantation for inborn errors of metabolism , 2006, Journal of Inherited Metabolic Disease.

[143]  P. Frediani,et al.  Neonatal mucolipidosis 2. The spontaneous evolution of early bone lesions and the effect of vitamin D treatment , 1989, Pediatric Radiology.

[144]  V. Kimonis,et al.  Krabbe Disease: Severe Neonatal Presentation With a Family History of Multiple Sclerosis , 2005, Journal of child neurology.

[145]  M. Poe,et al.  Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. , 2004, The New England journal of medicine.

[146]  J. M. Aerts,et al.  Manifestations of Fabry disease in placental tissue , 2006, Journal of Inherited Metabolic Disease.

[147]  C. D. de Die-Smulders,et al.  Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites , 1999, Journal of Inherited Metabolic Disease.

[148]  M. Beck New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy , 2007, Human Genetics.

[149]  R. Bouvier,et al.  [Diagnosis of lysosomal storage diseases with fetal presentation]. , 1997, Annales de pathologie.

[150]  David M. Rapoport,et al.  Pompe disease diagnosis and management guideline , 2006, Genetics in Medicine.

[151]  P. Bauer,et al.  Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K. , 2003, Neuropediatrics.

[152]  H. Hoyme,et al.  Presentation of mucopolysaccharidosis VII (beta-glucuronidase deficiency) in infancy. , 1981, Journal of medical genetics.

[153]  E. Sidransky,et al.  The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease. , 1996, Journal of medical genetics.

[154]  M. Adachi,et al.  Fine structure of central nervous system in early infantile Gaucher's disease. , 1967, Archives of pathology.

[155]  N. Conradi,et al.  Infantile galactosialidosis presenting with congenital adrenal hyperplasia and renal hypertension. , 1993, Pediatric neurology.

[156]  R. Schiffmann,et al.  Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease , 2006, Clinical genetics.

[157]  J. Wagner,et al.  Hematopoietic cell therapy for metabolic disease. , 2007, The Journal of pediatrics.

[158]  C. Riely,et al.  Niemann-Pick variant lipidosis presenting as "neonatal hepatitis". , 1986, Journal of pediatric gastroenterology and nutrition.

[159]  G. Donnell,et al.  β-Glucuronidase Deficiency: A Heterogeneous Mucopolysaccharidosis , 1985 .

[160]  F. Graham,et al.  Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus‐mediated expression , 2004, Human mutation.

[161]  K. Nicolaides,et al.  The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. , 1985, American journal of obstetrics and gynecology.

[162]  D. Sherer,et al.  Gaucher Disease in the Neonate: A Distinct Gaucher Phenotype Is Analogous to a Mouse Model Created by Targeted Disruption of the Glucocerebrosidase Gene , 1992, Pediatric Research.

[163]  A. Beaudet,et al.  Variation in the phenotypic expression of beta-glucuronidase deficiency. , 1975, The Journal of pediatrics.

[164]  E. Ginns,et al.  Epidermal Abnormalities May Distinguish Type 2 from Type 1 and Type 3 of Gaucher Disease , 1996, Pediatric Research.

[165]  J. Alroy,et al.  Infantile sialic acid storage disease associated with renal disease. , 1988, Pediatric neurology.